Key statistics
As of last trade Collegium Pharmaceutical Inc (354:DUS) traded at 34.60, -7.98% below its 52-week high of 37.60, set on Mar 28, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 34.60 |
---|---|
High | 34.60 |
Low | 34.60 |
Bid | 34.60 |
Offer | 35.60 |
Previous close | 34.40 |
Average volume | 0.00 |
---|---|
Shares outstanding | 32.21m |
Free float | 31.79m |
P/E (TTM) | 17.01 |
Market cap | 1.26bn USD |
EPS (TTM) | 2.30 USD |
Data delayed at least 15 minutes, as of Sep 23 2024 11:30 BST.
More ▼
Announcements
- Collegium Completes Acquisition of Ironshore Therapeutics
- Collegium to Participate in H.C. Wainwright 26th Annual Global Investment Conference
- Collegium Announces Eight Poster Presentations at PAINWeek Conference 2024
- Collegium Reports Second Quarter 2024 Financial Results
- Collegium to Acquire Ironshore Therapeutics, Expanding into Neurology
- Collegium to Report Second Quarter 2024 Financial Results on August 8, 2024
- Collegium Obtains Six Month Extension of U.S. Pediatric Exclusivity for Nucynta Franchise
- Collegium to Participate in Jefferies Global Healthcare Conference
- Collegium Announces $35 Million Accelerated Share Repurchase Program
- Collegium Reports First Quarter 2024 Financial Results
More ▼